ST Pharm Co.,Ltd. (237690.KQ)

KRW 79400.0

(0.51%)

Total Assets Summary of ST Pharm Co.,Ltd.

ST Pharm Co.,Ltd.'s latest annual total assets in 2023 was 686.83 Billion KRW , up 19.07% from previous year.
ST Pharm Co.,Ltd.'s latest quarterly total assets in 2024 Q1 was 675.82 Billion KRW , down -1.6% from previous quarter.
ST Pharm Co.,Ltd. reported annual total assets of 576.81 Billion KRW in 2022, up 14.16% from previous year.
ST Pharm Co.,Ltd. reported annual total assets of 505.24 Billion KRW in 2021, up 11.95% from previous year.
ST Pharm Co.,Ltd. reported quarterly total assets of 675.82 Billion KRW for 2024 Q1, down -1.6% from previous quarter.
ST Pharm Co.,Ltd. reported quarterly total assets of 555.73 Billion KRW for 2023 Q2, down -3.27% from previous quarter.

Annual Total Assets Chart of ST Pharm Co.,Ltd. (2023 - 2015)

Historical Annual Total Assets of ST Pharm Co.,Ltd. (2023 - 2015)

Year	Total Assets	Total Assets Growth
2023	686.83 Billion KRW	19.07%
2022	576.81 Billion KRW	14.16%
2021	505.24 Billion KRW	11.95%
2020	451.33 Billion KRW	31.02%
2019	344.46 Billion KRW	-1.36%
2018	349.21 Billion KRW	-9.34%
2017	385.21 Billion KRW	3.73%
2016	371.36 Billion KRW	59.82%
2015	232.36 Billion KRW	0.0%

Year	Total Assets	Total Assets Growth
2024 Q2	666.21 Billion KRW	-1.42%
2024 Q1	675.82 Billion KRW	-1.6%
2023 Q2	555.73 Billion KRW	-3.27%
2023 Q4	686.83 Billion KRW	5.89%
2023 FY	686.83 Billion KRW	19.07%
2023 Q1	574.54 Billion KRW	-0.39%
2023 Q3	648.61 Billion KRW	16.71%
2022 Q3	538.76 Billion KRW	1.9%
2022 FY	576.81 Billion KRW	14.16%
2022 Q4	576.81 Billion KRW	7.06%
2022 Q2	528.72 Billion KRW	4.24%
2022 Q1	507.23 Billion KRW	0.39%
2021 Q4	505.24 Billion KRW	3.68%
2021 Q1	445.95 Billion KRW	0.09%
2021 Q2	469.74 Billion KRW	5.33%
2021 Q3	487.3 Billion KRW	3.74%
2021 FY	505.24 Billion KRW	11.95%
2020 Q1	340.38 Billion KRW	-0.07%
2020 FY	451.33 Billion KRW	31.02%
2020 Q4	445.57 Billion KRW	31.57%
2020 Q3	338.64 Billion KRW	-0.88%
2020 Q2	341.64 Billion KRW	0.37%
2019 Q2	329.66 Billion KRW	-3.4%
2019 Q3	330.54 Billion KRW	0.27%
2019 Q4	340.6 Billion KRW	3.04%
2019 Q1	341.27 Billion KRW	-1.22%
2019 FY	344.46 Billion KRW	-1.36%
2018 Q1	376.35 Billion KRW	-1.35%
2018 FY	349.21 Billion KRW	-9.34%
2018 Q3	353.61 Billion KRW	-3.43%
2018 Q2	366.16 Billion KRW	-2.71%
2018 Q4	345.5 Billion KRW	-2.29%
2017 Q2	373.8 Billion KRW	-3.86%
2017 Q1	388.79 Billion KRW	5.71%
2017 Q4	381.5 Billion KRW	0.68%
2017 FY	385.21 Billion KRW	3.73%
2017 Q3	378.93 Billion KRW	1.37%
2016 Q4	367.77 Billion KRW	6.64%
2016 Q2	380.86 Billion KRW	0.0%
2016 Q1	- KRW	-100.0%
2016 Q3	344.86 Billion KRW	-9.45%
2016 FY	371.36 Billion KRW	59.82%
2015 FY	232.36 Billion KRW	0.0%
2015 Q4	232.36 Billion KRW	0.0%

Peer Total Assets Comparison of ST Pharm Co.,Ltd.

Name	Total Assets	Total Assets Difference
Sam Chun Dang Pharm. Co., Ltd	408.02 Billion KRW	-68.332%
Hyundai Bioscience Co., Ltd.	52.79 Billion KRW	-1201.02%
ABL Bio Inc.	160.14 Billion KRW	-328.882%
Cellid, Co., Ltd.	63.92 Billion KRW	-974.479%